Singapour #9108 (v.2)
Données de base
- Notifiée dans
-
G/MA/QR/N/SGP/7 06/11/2024
- Validité de la version
-
01/09/2024 -
actuelle
Version active v.2
- Membre présentant le rapport
- Singapour
- En vigueur depuis
- Date de fin
- En vigueur
- Description générale
-
Non-automatic licence for the import of Cell, Tissue, and Gene Therapy Products
- Base légale nationale
-
Health Products Act, 2007
&
Health Products (Cell, Tissue, and Gene Therapy Products) Regulations, 2021
Date of Entry into force:
1 March 2021
The latest version of the measure became effective on 18 December 2023
- Mécanisme administratif
-
The regulation of cell, tissue and gene therapy products is under the Health Products (Cell, Tissue and Gene Therapy_ Regulations 2021.
More information can be found at: https://www.hsa.gov.sg/ctgtp/dealers-licence.
Administered by HSA. - Entités responsables
-
Health Sciences Authority
- Version du SH
-
HS 2022
- Cote du document de l'OMC mentionné
Métadonnées
- Justifications au regard de l'OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Signalé comme: Article XX(b) of the GATT - Engagements internationaux (hors OMC)
-
- Partenaires concernés
- Partenaires non concernés
Mesures
- Restrictions signalées
- NAL
| Cote |
|---|
|
NAL
|
Lignes tarifaires
|
30
|
Chapter 30
|
Cell, tissue, and gene therapy products refer to cellular-, tissue- or gene-based therapeutic produc...
|
|